Ask Warren

Curiox Biosystems

445680 · KOSDAQ · ₩445680 · 큐리옥스바이오시스템즈

₩60,600▼ ₩1,800 (2.88%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩1.2B₩1.3B₩1.8B₩1.4B₩996M₩922M₩956M₩951M
Cost of sales₩738M₩758M₩859M₩567M₩1.3B₩305M₩345M₩442M
Gross profit₩438M₩567M₩990M₩818M−₩289M₩617M₩611M₩510M
Operating income−₩4.5B−₩3.3B−₩2.7B−₩2.7B−₩4B−₩3B−₩3.6B−₩3.3B
Net income−₩2.2B−₩2.6B−₩24B₩15B−₩15B−₩3.6B−₩4.1B−₩943M
Net income to shareholders−₩4.8B−₩2.6B−₩2.3B−₩3B−₩18B−₩3.6B₩1.7B−₩4B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩53B₩78B₩78B₩65B₩65B₩68B₩71B₩72B
Current assets₩14B₩38B₩40B₩28B₩29B₩30B₩32B₩35B
Cash and equivalents₩11B₩10B₩15B₩18B₩20B₩11B₩24B₩30B
Total liabilities₩4.3B₩26B₩25B₩11B₩38B₩22B₩22B₩27B
Current liabilities₩2.6B₩24B₩23B₩9.2B₩36B₩20B₩20B₩25B
Borrowings₩0₩1.9B₩1.8B₩1.7B₩8.2B₩7.8B₩7.4B₩7B
Total equity₩49B₩52B₩53B₩54B₩27B₩46B₩49B₩46B
Shareholders' equity₩49B₩52B₩53B₩54B₩27B₩46B₩49B₩46B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩2.8B−₩1.1B−₩3.1B−₩2.3B−₩2.6B−₩3.2B−₩2.1B−₩2.9B
Capital spending₩23M₩12M₩22M₩23M₩82M₩9.8M₩141M₩328,923
Free cash flow−₩2.8B−₩1.1B−₩3.1B−₩2.3B−₩2.7B−₩3.2B−₩2.2B−₩2.9B

Consolidated where available. Amounts in won.

Also known as: Curiox Biosystems / 큐리옥스바이오시스템즈 / 445680 / KRX:445680

Source: KRX statistical information